Principal Investigator
Emily Jonczak
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20230173
Clinical Trial Summary
A Phase 2 Multicenter, Open-Label Study Of The CDK4/6 Inhibitor SPH4336 In Subjects With Locally Advanced Or Metastatic Liposarcomas
Phase
Phase II
Funding Agency/Sponsor
Industrial
Disease
Bone and Soft Tissue Cancers
Contact Information
Phone Number
305-243-2647